Boston Common Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-327,410
| Closed | -$10.9M | – | 195 |
|
|
2017
Q2 | $10.9M | Buy |
327,410
+96,110
| +42% | +$3.19M | 1.43% | 15 |
|
|
2017
Q1 | $7.42M | Sell |
231,300
-30,645
| -12% | -$983K | 1.01% | 28 |
|
|
2016
Q4 | $9.5M | Buy |
261,945
+74,990
| +40% | +$2.72M | 1.39% | 17 |
|
|
2016
Q3 | $8.6M | Sell |
186,955
-1,720
| -0.9% | -$79.1K | 0.47% | 76 |
|
|
2016
Q2 | $9.48M | Sell |
188,675
-3,370
| -2% | -$169K | 0.54% | 73 |
|
|
2016
Q1 | $10.3M | Buy |
+192,045
| New | +$10.3M | 0.58% | 71 |
|